Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2026-04-02 @ 4:43 AM
Study NCT ID:
NCT00551759
Status:
TERMINATED
Last Update Posted:
2023-07-03
First Post:
2007-10-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CDR0000571857
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |